Download raw/aaer/2016/AAER-3744.txt from codewithdark/SEC-RPT-Panel: direct link, hf CLI and curl.
- Browser
- Download file 17.5 kB
-
https://huggingface.co/datasets/codewithdark/SEC-RPT-Panel/resolve/main/raw/aaer/2016/AAER-3744.txt
- Command line
-
hf download hf://datasets/codewithdark/SEC-RPT-Panel/raw/aaer/2016/AAER-3744.txt
-
curl -L -o AAER-3744.txt https://huggingface.co/datasets/codewithdark/SEC-RPT-Panel/resolve/main/raw/aaer/2016/AAER-3744.txt
17.5 kB
| UNITED STATES OF AMERICA | |
| Before the | |
| SECURITIES AND EXCHANGE COMMISSION | |
| SECURITIES EXCHANGE ACT OF 1934 | |
| Release No. 77161 / February 17, 2016 | |
| ACCOUNTING AND AUDITING ENFORCEMENT | |
| Release No. 3744 / February 17, 2016 | |
| ADMINISTRATIVE PROCEEDING | |
| File No. 3-17120 | |
| In the Matter of | |
| DONALD J. GLIDEWELL, | |
| CPA | |
| Respondent. | |
| ORDER INSTITUTING CEASE-AND- | |
| DESIST PROCEEDINGS PURSUANT TO | |
| SECTION 21C OF THE SECURITIES | |
| EXCHANGE ACT OF 1934, MAKING | |
| FINDINGS, AND IMPOSING A CEASE- | |
| AND-DESIST ORDER | |
| I. | |
| The Securities and Exchange Commission (“Commission”) deems it appropriate that cease- | |
| and-desist proceedings be, and hereby are, instituted pursuant to Section 21C of the Securities | |
| Exchange Act of 1934 (“Exchange Act”), against Donald J. Glidewell (“the Respondent”). | |
| II. | |
| In anticipation of the institution of these proceedings, the Respondent has submitted an | |
| Offer of Settlement (the “Offer”), that the Commission has determined to accept. Solely for the | |
| purpose of these proceedings and any other proceedings brought by or on behalf of the | |
| Commission, or to which the Commission is a party, and without admitting or denying the findings | |
| herein, except as to the Commission’s jurisdiction over him and over the subject matter of these | |
| proceedings, which are admitted, Respondent consents to the entry of this Order Instituting Cease- | |
| and-Desist Proceedings Pursuant to Section 21C of the Securities Exchange Act of 1934, Making | |
| Findings, and Imposing a Cease-and-Desist Order (“Order”), as set forth below. | |
| 2 | |
| III. | |
| On the basis of this Order and the Respondent’s Offer, the Commission finds1 that: | |
| Summary | |
| 1. This matter involves misstated revenues at Marrone Bio Innovations, Inc. (“MBI” | |
| or “the Company”), a Davis, California-based company that manufactures and sells biological- | |
| based pest management and plant health products. The misstatements were the result of MBI’s | |
| former Chief Operating Officer and Head of Sales directing MBI’s sales employees to offer | |
| various sales concessions to MBI’s distributors in order to meet sales targets and analysts’ revenue | |
| expectations, while simultaneously concealing those concessions from MBI’s finance and | |
| accounting personnel. Accordingly, MBI improperly and prematurely recognized more than $4 | |
| million in revenue from March 2013 through June 2014 (the “relevant period”), including $2 | |
| million in revenue that will never be recognized because the distributors returned the product to | |
| MBI. | |
| 2. As a result, MBI reported materially false financial results in its financial | |
| statements filed with the Commission over the period from July 1, 2013 through May 15, 2014. | |
| On September 3, 2014, MBI announced that its previously filed financial statements could not be | |
| relied upon. On November 10, 2015, MBI filed with the Commission restated financial statements | |
| for its 2013 quarterly and annual periods, as well as the quarterly periods ended March 31, 2014 | |
| and June 30, 2014. | |
| 3. MBI’s former Chief Financial Officer, Donald J. Glidewell, received bonuses | |
| during the 12-month periods following the filings containing financial results that MBI has restated | |
| as a result of misconduct. The Commission does not allege that Glidewell participated in the | |
| misconduct giving rise to the restatement. Glidewell has not, however, reimbursed MBI for those | |
| bonuses as required under Section 304(a) of the Sarbanes-Oxley Act. | |
| Respondent | |
| 4. Donald J. Glidewell, age 59, is a resident of Benicia, California. He served as | |
| MBI’s Chief Financial Officer from April 2011 until his resignation in March 2014. Glidewell is a | |
| certified public accountant licensed in California. Before joining MBI, Glidewell served as the | |
| CFO at a private company in the Sacramento area from 2000 to 2007 and as a Senior Director of | |
| Finance at the U.S. subsidiary of a Japanese-based public company from 2007 to 2011. | |
| 1 The findings herein are made pursuant to Respondent’s Offer of Settlement and | |
| is not binding on any other person or entity in this or any other proceeding. | |
| 3 | |
| Other Relevant Entity | |
| 5. MBI is a public company incorporated in Delaware and headquartered in Davis, | |
| California. At all relevant times, MBI’s common stock has been registered under Section 12(b) of | |
| the Exchange Act. MBI had its initial public offering (“IPO”), in August 2013, after which its | |
| stock traded on the Nasdaq Global Market under the ticker symbol “MBII”. On June 6, 2014, MBI | |
| undertook both a secondary and a follow-on offering in which it netted $39.9 million. On | |
| November 10, 2015, MBI restated its financial statements for its year ended December 31, 2013, as | |
| well as its quarterly results for the periods ended March 31, 2013, June 30, 2013, September 30, | |
| 2013, March 31, 2014, and June 30, 2014. | |
| Facts | |
| MBI Conducts an Initial Public Offering and Issues Revenue Guidance | |
| 6. On September 12, 2013, MBI held its first quarterly earnings call where it | |
| announced that revenues for the first six months of 2013 totaled $7.2 million and that MBI | |
| expected revenues for 2013 to double those of 2012 (which were $7.1 million). After that, MBI’s | |
| senior leaders consistently urged MBI’s employees to ensure the Company met its goal; the | |
| doubling of revenue became a key financial metric for MBI’s leadership. Analysts covering MBI | |
| cared about the Company’s expected sales and sales growth and the doubling of revenue was the | |
| only guidance that MBI’s management provided to analysts. | |
| 7. MBI primarily sold its products to distributors who would then sell the product to | |
| growers and other end users. MBI historically recognized revenue on a “sell-in” basis, which | |
| meant that it recognized revenue upon sale to a distributor rather than waiting to recognize revenue | |
| until products were sold to the ultimate grower or end user. This was appropriate under MBI’s | |
| revenue recognition policy as long as persuasive evidence of an arrangement existed, delivery and | |
| transfer of title had occurred or services had been rendered, the price was fixed and determinable, | |
| and collectability was reasonably assured and no contingencies existed. MBI’s revenue | |
| recognition policy did not allow for recognition of revenue at the time of sale if any | |
| contingencies—such as rights of return, or extended payment terms—were offered; rather, revenue | |
| could be recognized only once the contingencies expired. | |
| MBI Sales Employees Offer, And Hide From MBI’s Accounting Department, Numerous | |
| Sales Concessions to Meet Previously-Announced Revenue Targets | |
| 8. Towards the end of 2013, MBI’s former Chief Operating Officer became concerned | |
| that MBI might not meet its goal of doubling its 2012 revenue because its distributors did not have | |
| any more capacity to buy MBI’s products. To close the gap, MBI’s former COO—then Head of | |
| Sales—instructed his sales employees to offer inventory protection on deals to ensure they moved | |
| as much product as they could by the end of the year. The inventory protection offered took three | |
| general forms: (1) rights to return unsold product; (2) credit and re-bill arrangements, which | |
| 4 | |
| extended payment dates beyond the originally agreed-upon terms; and (3) allowing payment for | |
| products upon sales to the end user, rather than pursuant to stated payment terms with the | |
| distributor. | |
| 9. In addition to offering inventory protection on certain deals in the first and second | |
| quarters of MBI’s 2013 fiscal year, the former COO and other MBI sales employees offered | |
| significantly more inventory protection towards the end of the year. During the relevant period, | |
| MBI’s former COO offered, and directed others to offer, inventory protection on at least eleven | |
| sales transactions totaling approximately $4 million. | |
| 10. MBI’s former COO knew that inventory protection could preclude immediate | |
| revenue recognition on deals sold through to distributors and that MBI’s accounting department | |
| needed to know the terms of all sales transactions to ensure MBI’s revenue was accurately | |
| recorded and reported. Respondent Glidewell, MBI’s chief executive officer, and MBI’s controller | |
| told the former COO on multiple occasions throughout 2013 and 2014 about the revenue | |
| implications of offering inventory protection. | |
| 11. Despite knowing that it was important for MBI’s accounting department to be | |
| aware of all terms and conditions of each sales transaction, MBI’s former COO instructed MBI’s | |
| employees to conceal the inventory protection terms from MBI’s accountants. For example, in late | |
| 2013, he instructed MBI’s former Customer Service Manager to hide a side letter in her office | |
| desk, which detailed inventory protection on a large sales transaction transacted late in the fourth | |
| quarter of 2013. He also instructed the former Customer Service Manager to physically remove | |
| the inventory protection terms from the face of a purchase order on another sales transaction. | |
| These actions caused MBI to file financial statements that were not in accordance with GAAP. See | |
| Accounting Standards Codification 605-15-25-1. | |
| 12. Additionally, despite knowing he personally had offered, and authorized his sales | |
| employees to offer, inventory protection on several sales transactions in 2013 and 2014, MBI’s | |
| former COO consistently denied knowing about transactions with inventory protection in several | |
| quarterly and annual disclosure committee meetings, the purpose of which was to help MBI’s | |
| accounting department ensure that MBI appropriately recorded and reported its revenue. MBI’s | |
| former COO also lied on a sales certification provided to him by MBI’s independent auditor in | |
| connection with their year-end 2013 audit by certifying in writing that he was not aware of any | |
| terms or conditions MBI had agreed to with distributors that were not reflected in written | |
| agreements or purchase orders. | |
| 13. On March 6, 2014, MBI held its 2013 full-year earnings call. During the call, | |
| MBI’s former COO attributed the Company’s achievement of doubling its 2012 revenue to the | |
| successful launch of a new product into row crops in the Midwest and the stellar performance of | |
| another product in its first full year of sales. | |
| 14. On March 25, 2014, MBI filed its 2013 Form 10-K with the Commission. | |
| Revenue, as reported, more than doubled from $7.1 million in 2012 to $14.5 million in 2013. | |
| 5 | |
| 15. MBI’s former COO, as well as several of his sales employees, continued to offer | |
| inventory protection throughout at least the first quarter of 2014 and continued to hide it from | |
| MBI’s accounting department. All told, MBI’s former COO caused MBI to improperly recognize | |
| revenue on at least eleven sales transactions totaling approximately $4 million. Without offering | |
| inventory protection on these sales transactions, MBI would have missed its doubling-of-revenue | |
| target for 2013 because many of the Company’s distributors would not have purchased its products | |
| without assurances that they could return them in the future. | |
| 16. MBI’s former COO also engaged in other fraudulent conduct to maximize revenue | |
| and allow MBI to recognize revenue earlier than allowed under GAAP. During 2013, the former | |
| COO instructed employees in MBI’s supply chain department to ship the wrong product to a | |
| distributor and in early 2014, the former COO directed MBI’s former Customer Relations Manager | |
| to backdate a shipping document. In an additional attempt to book certain sales transactions, the | |
| former COO authorized MBI to pay a distributor’s freight costs and storage fees, and then directed | |
| the former Customer Relations Manager to mischaracterize these expenses as promotional | |
| marketing expenses in the Company’s books and records, resulting in MBI filing financial | |
| statements that were not in accordance with GAAP. See Accounting Standards Codification 605- | |
| 50-45-2. | |
| Scope and Impact of the Fraud at MBI | |
| 17. MBI’s revenues were materially overstated in its financial statements filed with the | |
| Commission as a result of the hidden inventory protection. Specifically, MBI misstated its | |
| financial statements in Forms 10-Q and 10-K for fiscal year 2013 and Forms 10-Q for 2014. MBI | |
| also misstated its financial statements in the Company’s Forms S-1 filed on July 1, 2013 and May | |
| 16, 2014. Finally, MBI incorporated the misstated first quarter 2013 financial statements, as | |
| included in the first Form S-1, in its Form S-8 filed on September 6, 2013. | |
| 18. These misstatements are material. Without the inventory protection on several | |
| sales transactions in 2013, MBI would not have doubled its 2012 revenue and would have missed | |
| its revenue target for the year. MBI’s distributors returned approximately $2 million in product | |
| after June 30, 2014 pursuant to inventory protection rights and the Company will not recognize this | |
| revenue in any future period. | |
| MBI’s Restatement | |
| 19. On September 3, 2014, MBI announced that its Audit Committee had commenced | |
| an independent investigation into whether revenue for a particular transaction had been | |
| appropriately recognized. It also announced that it had concluded, after consultation with | |
| management, that its previously reported financial statements as of December 31, 2013, included | |
| in its annual report on Form 10-K for the year ended December 31, 2013, and the unaudited | |
| interim financial statements included in the Company’s quarterly reports on Forms 10-Q for the | |
| quarters ended March 31, 2014 and June 30, 2014, should no longer be relied upon. | |
| 6 | |
| 20. On November 10, 2015, MBI filed with the Commission restated financial results, | |
| for its quarterly periods ending March 31, 2013, June 30, 2013, September 30, 2013, March 31, | |
| 2014, and June 30, 2014, as well as its annual results for the year ended December 31, 2013. For | |
| certain distributors, MBI changed its method of recognizing revenue from “sell-in” to “sell- | |
| through,” meaning that, for those distributors, it will delay the recognition of revenue until the | |
| product is sold through to an end user. | |
| 21. In its restated Form 10-K, MBI disclosed that its Audit Committee had determined | |
| that, as a result of the failure of certain former employees to share with the Company’s accounting | |
| department or external auditor important transaction terms with distributors, including inventory | |
| protection agreements that would permit the distributors to return to the Company certain unsold | |
| products, the Company inappropriately recognized revenue for certain historical sales transactions | |
| prior to satisfying the criteria for revenue recognition required under GAAP. MBI also concluded | |
| that mitigating controls were not in place to discourage, prevent or detect management override of | |
| internal accounting control by certain sales personnel related to MBI’s process for recognizing | |
| revenue, and that its controls were not effectively designed to identify instances when sales | |
| personnel made unauthorized commitments with certain distributors, including inventory | |
| protection arrangements, that would permit the distributors to return to MBI certain unsold | |
| products. | |
| Compensation of CFO Glidewell | |
| 22. During the 12-month periods that followed the filing of the periodic reports | |
| requiring restatement, Glidewell received bonuses that were tied to MBI’s achievement of certain | |
| revenue targets. | |
| 23. Glidewell has not reimbursed those amounts to MBI. | |
| Violations | |
| 24. Section 304 of the Sarbanes-Oxley Act of 2002 requires the chief executive officer | |
| or chief financial officer of any issuer required to prepare an accounting restatement due to | |
| material noncompliance with the securities laws as a result of misconduct to reimburse the issuer | |
| for: (i) any bonus or incentive-based or equity-based compensation received by that person from | |
| the issuer during the 12-month periods following the false filings; and (ii) any profits realized from | |
| the sale of securities of the issuer during that 12-month periods. Section 304 does not require that a | |
| chief executive officer or chief financial officer engage in misconduct to trigger the reimbursement | |
| requirement. Glidewell received bonuses during the 12-month periods following the filings | |
| containing financial results that MBI was required to restate. He has not, to date, reimbursed the | |
| Company for those amounts. Glidewell has, therefore, violated Sarbanes-Oxley Section 304. | |
| 7 | |
| IV. | |
| In view of the foregoing, the Commission deems it appropriate to impose the sanctions | |
| agreed to in Respondent’s Offer. | |
| Accordingly, it is hereby ORDERED, pursuant to Section 21C of the Exchange Act, that: | |
| A. Respondent Glidewell cease and desist from committing or causing any violations | |
| and any future violations of Section 304 of the Sarbanes-Oxley Act. | |
| B. Respondent Glidewell shall, within 30 days of the entry of this Order, reimburse | |
| MBI for a total of $11,789 pursuant to Section 304(a) of SOX. Respondent shall simultaneously | |
| deliver proof of satisfying this reimbursement obligation to Erin E. Schneider, Division of | |
| Enforcement, Securities and Exchange Commission, 44 Montgomery Street, Suite 2800, San | |
| Francisco, California 94104. | |
| By the Commission. | |
| Brent J. Fields | |
| Secretary |